Biocorrx ROE 2012-2024 | BICX
Current and historical return on equity (ROE) values for Biocorrx (BICX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Biocorrx ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-12-31 | $0.00B | $-0.01B | 34.78% |
| 2024-09-30 | $0.00B | $-0.01B | 36.36% |
| 2024-06-30 | $0.00B | $-0.01B | 39.02% |
| 2024-03-31 | $0.00B | $-0.01B | 41.03% |
| 2023-12-31 | $0.00B | $-0.01B | 43.24% |
| 2023-09-30 | $0.00B | $-0.01B | 45.71% |
| 2023-06-30 | $0.00B | $-0.01B | 48.48% |
| 2023-03-31 | $0.00B | $-0.01B | 51.61% |
| 2022-12-31 | $0.00B | $-0.01B | 55.17% |
| 2022-09-30 | $0.00B | $-0.01B | 57.14% |
| 2022-06-30 | $0.00B | $-0.01B | 59.26% |
| 2022-03-31 | $0.00B | $-0.01B | 66.67% |
| 2021-12-31 | $-0.01B | $-0.01B | 100.00% |
| 2021-09-30 | $-0.01B | $-0.01B | 117.65% |
| 2021-06-30 | $-0.01B | $0.00B | 142.86% |
| 2021-03-31 | $-0.01B | $0.00B | 153.85% |
| 2020-12-31 | $0.00B | $0.00B | 133.33% |
| 2020-09-30 | $0.00B | $0.00B | 177.78% |
| 2020-06-30 | $0.00B | $0.00B | 266.67% |
| 2020-03-31 | $-0.01B | $0.00B | 333.33% |
| 2019-12-31 | $-0.01B | $0.00B | 240.00% |
| 2019-09-30 | $-0.01B | $0.00B | 186.67% |
| 2019-06-30 | $-0.01B | $0.00B | 160.00% |
| 2019-03-31 | $-0.01B | $-0.01B | 133.33% |
| 2018-12-31 | $-0.01B | $-0.01B | 126.32% |
| 2018-09-30 | $-0.01B | $-0.01B | 141.18% |
| 2018-06-30 | $-0.01B | $0.00B | 133.33% |
| 2018-03-31 | $0.01B | $0.00B | -215.38% |
| 2017-12-31 | $-0.03B | $0.00B | 226.42% |
| 2017-09-30 | $-0.03B | $0.00B | 210.53% |
| 2017-06-30 | $-0.03B | $0.00B | 209.84% |
| 2017-03-31 | $-0.04B | $-0.04B | 275.00% |
| 2016-12-31 | $-0.01B | $-0.01B | 116.67% |
| 2016-09-30 | $-0.01B | $-0.01B | 105.26% |
| 2016-06-30 | $0.00B | $-0.01B | 100.00% |
| 2016-03-31 | $-0.01B | $0.00B | 342.86% |
| 2015-12-31 | $-0.01B | $0.00B | 666.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.005B | $0.000B |
| BioCorRx Inc. is a healthcare solutions development company. It treats alcoholism and opioid addictions. The company's addiction treatment program consists of BioCorRx(R) Recovery Program. BioCorRx Inc. is headquartered in Santa Ana, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.427B | 26.15 |
| Elevance Health (ELV) | United States | $93.171B | 12.02 |
| CVS Health (CVS) | United States | $85.832B | 10.67 |
| Cencora (COR) | United States | $55.028B | 19.14 |
| Natera (NTRA) | United States | $21.977B | 0.00 |
| DiDi Global (DIDIY) | China | $20.426B | 31.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.484B | 0.00 |
| Solventum (SOLV) | United States | $11.527B | 12.20 |
| CochLear (CHEOY) | Australia | $11.409B | 0.00 |
| ICON (ICLR) | Ireland | $11.183B | 10.40 |
| Doximity (DOCS) | United States | $11.080B | 57.62 |
| Revvity (RVTY) | United States | $10.950B | 18.84 |
| Viatris (VTRS) | United States | $10.779B | 3.67 |
| Medpace Holdings (MEDP) | United States | $8.646B | 22.96 |
| Avantor (AVTR) | United States | $8.368B | 12.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.191B | 0.00 |
| HealthEquity (HQY) | United States | $7.900B | 38.86 |
| Charles River Laboratories (CRL) | United States | $6.943B | 13.60 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.064B | 23.96 |
| BrightSpring Health Services (BTSG) | United States | $3.924B | 36.32 |
| Sotera Health (SHC) | United States | $3.755B | 21.34 |
| Alignment Healthcare (ALHC) | United States | $3.051B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.907B | 33.35 |
| Concentras Parent (CON) | United States | $2.706B | 15.64 |
| Organon (OGN) | United States | $2.345B | 2.49 |
| Premier (PINC) | United States | $2.127B | 14.56 |
| Ardent Health Partners (ARDT) | United States | $2.078B | 8.88 |
| Progyny (PGNY) | United States | $2.002B | 44.09 |
| GoodRx Holdings (GDRX) | United States | $1.627B | 30.29 |
| PACS (PACS) | United States | $1.615B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.582B | 61.93 |
| Agilon Health (AGL) | United States | $1.333B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.242B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.240B | 9.44 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.004B | 0.00 | |
| CareDx (CDNA) | United States | $0.857B | 13.38 |
| AMN Healthcare Services Inc (AMN) | United States | $0.776B | 7.29 |
| Embecta (EMBC) | United States | $0.773B | 5.30 |
| QDM (QDMI) | Hong Kong, SAR China | $0.674B | 0.00 |
| Nutex Health (NUTX) | United States | $0.667B | 13.08 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.61 |
| Enhabit (EHAB) | United States | $0.491B | 40.38 |
| InnovAge Holding (INNV) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.464B | 0.00 |
| LifeMD (LFMD) | United States | $0.371B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.349B | 0.00 |
| SBC Medicals (SBC) | United States | $0.336B | 0.00 |
| DocGo (DCGO) | United States | $0.238B | 38.83 |
| Oncology Institute (TOI) | United States | $0.221B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.176B | 0.00 |
| Beauty Health (SKIN) | United States | $0.155B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
| So-Young (SY) | China | $0.085B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.081B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.080B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.051B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| KindlyMD (KDLY) | United States | $0.023B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |